It has been shown to be effective in inhibiting various types of cancers including those of the gastrointestinal tract, nasopharynx, liver, lung, ovary, soft tissues, and hematopoietic system including NPM-ALK+ T cell lymphoma [21, 34–46]. Here, ALK is linked to T-cell non-Hodgkin lymphoma.